Delivery Order SPE2DB24D1205-SPE2DB24FCSKY
Award Date
7/2/24
Potential Completion Date
7/24/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $4,620.93 for the supply of the drug Zeposia 0.92 mg capsules. The contract, awarded by the Defense Logistics Agency (DLA), has a completion date of December 23, 2024 and utilizes a firm fixed price pricing structure. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Zeposia 0.92 MG Capsule 30S. The contract is a firm fixed-price delivery order with a ceiling value of $13,399.71 and a completion date of July 22, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a single-award Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Zeposia 0.92 mg capsules in a 30-count package to the Defense Logistics Agency (DLA), a defense agency. The $17,866.28 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,399.71 firm fixed-price delivery order is for the supply of Zeposia 0.92 mg capsules, a specialty pharmaceutical product. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of Zeposia 0.92 MG Capsule 30s, a pharmaceutical product. The $4,466.57 firm fixed-price delivery order has a completion date of June 11, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of one of the world's largest pharmaceutical distributors, holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Zeposia 0.92 mg capsules to the Defense Logistics Agency (DLA). The $13,862.79 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 20, 2024. The contract has an ultimate completion date of December 12, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $4,620.93, is a delivery order for the drug Zeposia 0.92 mg capsule 30s. The contract has an ultimate completion date of April 21, 2025 and is a firm fixed-price contract. There is no set-aside designation mentioned. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4564688600 ZEPOSIA 0.92 MG CAPSULE 30S, with an ultimate completion date of June 13, 2024. The $8,933.14 firm-fixed-price delivery order was awarded on May 22, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025 with...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract valued at $8,933.14 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product ZEPOSIA 0.92 MG CAPSULE 30S. This award is under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award, valued at $13,862.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Zeposia 0.92 MG Capsule 30S, with a completion date of May 1, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...